Lumira Ventures is a North American healthcare venture capital firm with over two decades of experience investing in transformative biomedical companies. Established in 2007, the firm operates from offices in Toronto, Montréal, Vancouver, and Boston. Lumira Ventures focuses on biotechnology, medical devices, and digital health sectors, partnering with mission-driven entrepreneurs to develop innovative therapeutic solutions.

Their portfolio companies have collectively impacted the lives of over 1 billion patients worldwide and generated more than $75 billion in cumulative revenue. The firm has raised over $6 billion in capital for its portfolio companies and has a history of successful exits, including landmark FDA product approvals and significant IPOs.